Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Apr 15;339(Pt 2):363–370.

Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials.

P Loria 1, S Miller 1, M Foley 1, L Tilley 1
PMCID: PMC1220166  PMID: 10191268

Abstract

The malaria parasite feeds by degrading haemoglobin in an acidic food vacuole, producing free haem moieties as a by-product. The haem in oxyhaemoglobin is oxidized from the Fe(II) state to the Fe(III) state with the consequent production of an equimolar concentration of H2O2. We have analysed the fate of haem molecules in Plasmodium falciparum-infected erythrocytes and have found that only about one third of the haem is polymerized to form haemozoin. The remainder appears to be degraded by a non-enzymic process which leads to an accumulation of iron in the parasite. A possible route for degradation of the haem is by reacting with H2O2, and we show that, under conditions designed to resemble those found in the food vacuole, i.e., at pH5.2 in the presence of protein, free haem undergoes rapid peroxidative decomposition. Chloroquine and quinacrine are shown to be efficient inhibitors of the peroxidative destruction of haem, while epiquinine, a quinoline compound with very low antimalarial activity, has little inhibitory effect. We also show that chloroquine enhances the association of haem with membranes, while epiquinine inhibits this association, and that treatment of parasitized erythrocytes with chloroquine leads to a build-up of membrane-associated haem in the parasite. We suggest that chloroquine exerts its antimalarial activity by causing a build-up of toxic membrane-associated haem molecules that eventually destroy the integrity of the malaria parasite. We have further shown that resistance-modulating compounds, such as chlorpromazine, interact with haem and efficiently inhibit its degradation. This may explain the weak antimalarial activities of these compounds.

Full Text

The Full Text of this article is available as a PDF (170.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams P. A., Berman P. A., Egan T. J., Marsh P. J., Silver J. The iron environment in heme and heme-antimalarial complexes of pharmacological interest. J Inorg Biochem. 1996 Jul;63(1):69–77. doi: 10.1016/0162-0134(95)00212-x. [DOI] [PubMed] [Google Scholar]
  2. Aley S. B., Sherwood J. A., Marsh K., Eidelman O., Howard R. J. Identification of isolate-specific proteins on sorbitol-enriched Plasmodium falciparum infected erythrocytes from Gambian patients. Parasitology. 1986 Jun;92(Pt 3):511–525. doi: 10.1017/s0031182000065410. [DOI] [PubMed] [Google Scholar]
  3. Asakura T., Minakata K., Adachi K., Russell M. O., Schwartz E. Denatured hemoglobin in sickle erythrocytes. J Clin Invest. 1977 Apr;59(4):633–640. doi: 10.1172/JCI108681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Atamna H., Ginsburg H. Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol. 1993 Oct;61(2):231–241. doi: 10.1016/0166-6851(93)90069-a. [DOI] [PubMed] [Google Scholar]
  5. Awasthi Y. C., Beutler E., Srivastava S. K. Purification and properties of human erythrocyte glutathione peroxidase. J Biol Chem. 1975 Jul 10;250(13):5144–5149. [PubMed] [Google Scholar]
  6. Ben-Yoseph Y., Shapira E. Specific immunoassay for quantitative determination of human erythrocyte catalase. J Lab Clin Med. 1973 Jan;81(1):133–139. [PubMed] [Google Scholar]
  7. Bitonti A. J., Sjoerdsma A., McCann P. P., Kyle D. E., Oduola A. M., Rossan R. N., Milhous W. K., Davidson D. E., Jr Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science. 1988 Dec 2;242(4883):1301–1303. doi: 10.1126/science.3057629. [DOI] [PubMed] [Google Scholar]
  8. Blauer G., Akkawi M. Investigations of B- and beta-hematin. J Inorg Biochem. 1997 May 1;66(2):145–152. doi: 10.1016/s0162-0134(96)00200-0. [DOI] [PubMed] [Google Scholar]
  9. Bray P. G., Mungthin M., Ridley R. G., Ward S. A. Access to hematin: the basis of chloroquine resistance. Mol Pharmacol. 1998 Jul;54(1):170–179. doi: 10.1124/mol.54.1.170. [DOI] [PubMed] [Google Scholar]
  10. Brown S. B., Dean T. C., Jones P. Catalatic activity of iron(3)-centred catalysts. Role of dimerization in the catalytic action of ferrihaems. Biochem J. 1970 May;117(4):741–744. doi: 10.1042/bj1170741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brown S. B., Hatzikonstantinou H., Herries D. G. The role of peroxide in haem degradation. A study of the oxidation of ferrihaems by hydrogen peroxide. Biochem J. 1978 Sep 15;174(3):901–907. doi: 10.1042/bj1740901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cannon J. B., Kuo F. S., Pasternack R. F., Wong N. M., Muller-Eberhard U. Kinetics of the interaction of hemin liposomes with heme binding proteins. Biochemistry. 1984 Jul 31;23(16):3715–3721. doi: 10.1021/bi00311a022. [DOI] [PubMed] [Google Scholar]
  13. Carrell R. W., Winterbourn C. C., Rachmilewitz E. A. Activated oxygen and haemolysis. Br J Haematol. 1975 Jul;30(3):259–264. doi: 10.1111/j.1365-2141.1975.tb00540.x. [DOI] [PubMed] [Google Scholar]
  14. Carter P. Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal Biochem. 1971 Apr;40(2):450–458. doi: 10.1016/0003-2697(71)90405-2. [DOI] [PubMed] [Google Scholar]
  15. Chou A. C., Chevli R., Fitch C. D. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry. 1980 Apr 15;19(8):1543–1549. doi: 10.1021/bi00549a600. [DOI] [PubMed] [Google Scholar]
  16. Chou A. C., Fitch C. D. Control of heme polymerase by chloroquine and other quinoline derivatives. Biochem Biophys Res Commun. 1993 Aug 31;195(1):422–427. doi: 10.1006/bbrc.1993.2060. [DOI] [PubMed] [Google Scholar]
  17. Dorn A., Stoffel R., Matile H., Bubendorf A., Ridley R. G. Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature. 1995 Mar 16;374(6519):269–271. doi: 10.1038/374269a0. [DOI] [PubMed] [Google Scholar]
  18. Dubois V. L., Platel D. F., Pauly G., Tribouley-Duret J. Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. Exp Parasitol. 1995 Aug;81(1):117–124. doi: 10.1006/expr.1995.1099. [DOI] [PubMed] [Google Scholar]
  19. Eckman J. R., Modler S., Eaton J. W., Berger E., Engel R. R. Host heme catabolism in drug-sensitive and drug-resistant malaria. J Lab Clin Med. 1977 Oct;90(4):767–770. [PubMed] [Google Scholar]
  20. Fairfield A. S., Abosch A., Ranz A., Eaton J. W., Meshnick S. R. Oxidant defense enzymes of Plasmodium falciparum. Mol Biochem Parasitol. 1988 Jul;30(1):77–82. doi: 10.1016/0166-6851(88)90134-x. [DOI] [PubMed] [Google Scholar]
  21. Fitch C. D., Yunis N. G., Chevli R., Gonzalez Y. High-affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium berghei. J Clin Invest. 1974 Jul;54(1):24–33. doi: 10.1172/JCI107747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Foley M., Tilley L. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther. 1998 Jul;79(1):55–87. doi: 10.1016/s0163-7258(98)00012-6. [DOI] [PubMed] [Google Scholar]
  23. Gamain B., Langsley G., Fourmaux M. N., Touzel J. P., Camus D., Dive D., Slomianny C. Molecular characterization of the glutathione peroxidase gene of the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol. 1996 Jun;78(1-2):237–248. doi: 10.1016/s0166-6851(96)02632-1. [DOI] [PubMed] [Google Scholar]
  24. Geary T. G., Divo A. D., Jensen J. B., Zangwill M., Ginsburg H. Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. Implications for mechanism of action of and resistance to the drug. Biochem Pharmacol. 1990 Aug 15;40(4):685–691. doi: 10.1016/0006-2952(90)90302-2. [DOI] [PubMed] [Google Scholar]
  25. Ginsburg H., Demel R. A. Interactions of hemin, antimalarial drugs and hemin-antimalarial complexes with phospholipid monolayers. Chem Phys Lipids. 1984 Oct;35(4):331–347. doi: 10.1016/0009-3084(84)90076-8. [DOI] [PubMed] [Google Scholar]
  26. Hatzikonstantinou H., Brown S. B. Catalase model systems. Decomposition of hydrogen peroxide catalysed by mesoferrihaem, deuteroferrihaem, coproferrihaem and haematoferrihaem. Biochem J. 1978 Sep 15;174(3):893–900. doi: 10.1042/bj1740893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hunt N. H., Stocker R. Oxidative stress and the redox status of malaria-infected erythrocytes. Blood Cells. 1990;16(2-3):499–530. [PubMed] [Google Scholar]
  28. Kelder P. P., Fischer M. J., de Mol N. J., Janssen L. H. Oxidation of chlorpromazine by methemoglobin in the presence of hydrogen peroxide. Formation of chlorpromazine radical cation and its covalent binding to methemoglobin. Arch Biochem Biophys. 1991 Feb 1;284(2):313–319. doi: 10.1016/0003-9861(91)90301-x. [DOI] [PubMed] [Google Scholar]
  29. Kuzelová K., Mrhalová M., Hrkal Z. Kinetics of heme interaction with heme-binding proteins: the effect of heme aggregation state. Biochim Biophys Acta. 1997 Oct 20;1336(3):497–501. doi: 10.1016/s0304-4165(97)00062-7. [DOI] [PubMed] [Google Scholar]
  30. Kyle D. E., Milhous W. K., Rossan R. N. Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys. Am J Trop Med Hyg. 1993 Jan;48(1):126–133. doi: 10.4269/ajtmh.1993.48.126. [DOI] [PubMed] [Google Scholar]
  31. La Greca N., Hibbs A. R., Riffkin C., Foley M., Tilley L. Identification of an endoplasmic reticulum-resident calcium-binding protein with multiple EF-hand motifs in asexual stages of Plasmodium falciparum. Mol Biochem Parasitol. 1997 Nov;89(2):283–293. doi: 10.1016/s0166-6851(97)00134-5. [DOI] [PubMed] [Google Scholar]
  32. Macomber P. B., Sprinz H. Morphological effects of chloroquine on Plasmodium berghei in mice. Nature. 1967 May 27;214(5091):937–939. doi: 10.1038/214937a0. [DOI] [PubMed] [Google Scholar]
  33. Malhotra K., Salmon D., Le Bras J., Vilde J. L. Potentiation of chloroquine activity against Plasmodium falciparum by the peroxidase-hydrogen peroxide system. Antimicrob Agents Chemother. 1990 Oct;34(10):1981–1985. doi: 10.1128/aac.34.10.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Martin S. K., Oduola A. M., Milhous W. K. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science. 1987 Feb 20;235(4791):899–901. doi: 10.1126/science.3544220. [DOI] [PubMed] [Google Scholar]
  35. Martiney J. A., Cerami A., Slater A. F. Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect. J Biol Chem. 1995 Sep 22;270(38):22393–22398. doi: 10.1074/jbc.270.38.22393. [DOI] [PubMed] [Google Scholar]
  36. Moreau S., Perly B., Biguet J. Interactions de la chloroquine avcc la ferriprotoporphyrine IX. Etude par résonance magnétique nucléaire. Biochimie. 1982 Nov-Dec;64(11-12):1015–1025. doi: 10.1016/s0300-9084(82)80382-9. [DOI] [PubMed] [Google Scholar]
  37. Mueller S., Riedel H. D., Stremmel W. Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes. Blood. 1997 Dec 15;90(12):4973–4978. [PubMed] [Google Scholar]
  38. Ohsawa K., Tanabe K., Kimata I., Miki A. Ultrastructural changes associated with reversal of chloroquine resistance by verapamil in Plasmodium chabaudi. Parasitology. 1991 Oct;103(Pt 2):185–189. doi: 10.1017/s0031182000059461. [DOI] [PubMed] [Google Scholar]
  39. Raynes K., Foley M., Tilley L., Deady L. W. Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation. Biochem Pharmacol. 1996 Aug 23;52(4):551–559. doi: 10.1016/0006-2952(96)00306-1. [DOI] [PubMed] [Google Scholar]
  40. Raynes K., Galatis D., Cowman A. F., Tilley L., Deady L. W. Synthesis and activity of some antimalarial bisquinolines. J Med Chem. 1995 Jan 6;38(1):204–206. doi: 10.1021/jm00001a026. [DOI] [PubMed] [Google Scholar]
  41. Riggs A. Preparation of blood hemoglobins of vertebrates. Methods Enzymol. 1981;76:5–29. doi: 10.1016/0076-6879(81)76111-1. [DOI] [PubMed] [Google Scholar]
  42. Rosenthal P. J., Meshnick S. R. Hemoglobin catabolism and iron utilization by malaria parasites. Mol Biochem Parasitol. 1996 Dec 20;83(2):131–139. doi: 10.1016/s0166-6851(96)02763-6. [DOI] [PubMed] [Google Scholar]
  43. Sanchez C. P., Wünsch S., Lanzer M. Identification of a chloroquine importer in Plasmodium falciparum. Differences in import kinetics are genetically linked with the chloroquine-resistant phenotype. J Biol Chem. 1997 Jan 31;272(5):2652–2658. doi: 10.1074/jbc.272.5.2652. [DOI] [PubMed] [Google Scholar]
  44. Slater A. F., Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature. 1992 Jan 9;355(6356):167–169. doi: 10.1038/355167a0. [DOI] [PubMed] [Google Scholar]
  45. Slater A. F., Swiggard W. J., Orton B. R., Flitter W. D., Goldberg D. E., Cerami A., Henderson G. B. An iron-carboxylate bond links the heme units of malaria pigment. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):325–329. doi: 10.1073/pnas.88.2.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sugioka Y., Suzuki M., Sugioka K., Nakano M. A ferriprotoporphyrin IX-chloroquine complex promotes membrane phospholipid peroxidation. A possible mechanism for antimalarial action. FEBS Lett. 1987 Nov 2;223(2):251–254. doi: 10.1016/0014-5793(87)80299-5. [DOI] [PubMed] [Google Scholar]
  47. Sullivan D. J., Jr, Gluzman I. Y., Goldberg D. E. Plasmodium hemozoin formation mediated by histidine-rich proteins. Science. 1996 Jan 12;271(5246):219–222. doi: 10.1126/science.271.5246.219. [DOI] [PubMed] [Google Scholar]
  48. Wallace W. J., Houtchens R. A., Maxwell J. C., Caughey W. S. Mechanism of autooxidation for hemoglobins and myoglobins. Promotion of superoxide production by protons and anions. J Biol Chem. 1982 May 10;257(9):4966–4977. [PubMed] [Google Scholar]
  49. Ward S. A., Bray P. G., Hawley S. R. Quinoline resistance mechanisms in Plasmodium falciparum: the debate goes on. Parasitology. 1997;114 (Suppl):S125–S136. [PubMed] [Google Scholar]
  50. Warhurst D. C. The quinine-haemin interaction and its relationship to antimalarial activity. Biochem Pharmacol. 1981 Dec 15;30(24):3323–3327. doi: 10.1016/0006-2952(81)90606-7. [DOI] [PubMed] [Google Scholar]
  51. Wood P. A., Eaton J. W. Hemoglobin catabolism and host-parasite heme balance in chloroquine-sensitive and chloroquine-resistant Plasmodium berghei infections. Am J Trop Med Hyg. 1993 Apr;48(4):465–472. doi: 10.4269/ajtmh.1993.48.465. [DOI] [PubMed] [Google Scholar]
  52. Yayon A., Cabantchik Z. I., Ginsburg H. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 1984 Nov;3(11):2695–2700. doi: 10.1002/j.1460-2075.1984.tb02195.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Yayon A., Timberg R., Friedman S., Ginsburg H. Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. J Protozool. 1984 Aug;31(3):367–372. doi: 10.1111/j.1550-7408.1984.tb02981.x. [DOI] [PubMed] [Google Scholar]
  54. Zhang Y., Hempelmann E. Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins. Biochem Pharmacol. 1987 Apr 15;36(8):1267–1273. doi: 10.1016/0006-2952(87)90080-3. [DOI] [PubMed] [Google Scholar]
  55. el-Shoura S. M. Falciparum malaria in naturally infected human patients: VIII. Fine structure of intraerythrocytic asexual forms before and during chloroquine treatment. Appl Parasitol. 1994 Sep;35(3):207–218. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES